<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report"><?OLF?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Rev Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Nat. Rev. Microbiol</journal-id><journal-title-group><journal-title>Nature Reviews. Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1740-1526</issn><issn pub-type="epub">1740-1534</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7371787</article-id><article-id pub-id-type="publisher-id">421</article-id><article-id pub-id-type="doi">10.1038/s41579-020-0421-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genome Watch</subject></subj-group></article-categories><title-group><article-title>Genomics and epidemiological surveillance</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Lo</surname><given-names>Stephanie W.</given-names></name><address><email>microbes@sanger.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Jamrozy</surname><given-names>Dorota</given-names></name><address><email>microbes@sanger.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0606 5382</institution-id><institution-id institution-id-type="GRID">grid.10306.34</institution-id><institution>Parasites and Microbes, Wellcome Sanger Institute, Wellcome Genome Campus, </institution></institution-wrap>Hinxton, UK </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>7</month><year>2020</year></pub-date><fpage>1</fpage><lpage>1</lpage><permissions><copyright-statement>&#x000a9; Springer Nature Limited 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1" abstract-type="Standfirst"><p id="Par1">This month&#x02019;s Genome Watch highlights how genomic surveillance can provide important information for identifying and tracking emerging pathogens such as SARS-CoV-2.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Infectious-disease diagnostics</kwd><kwd>Metagenomics</kwd><kwd>SARS virus</kwd></kwd-group></article-meta></front><body><p id="Par2">The timely detection and surveillance&#x000a0;of infectious diseases and responses to pandemics are crucial but challenging. Whole-genome sequencing (WGS) is a common tool for pathogen identification and tracking, establishing transmission routes and outbreak control.</p><p id="Par3">At the turn of 2019/20, Wu et al<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> used metagenomic RNA sequencing to identify the aetiology of an at this point unknown respiratory disease in a single patient in Wuhan, China, where several cases of severe respiratory infections have been reported. The authors identified the potential causative pathogen as a new coronavirus by reconstructing the viral genome from the bronchoalveolar lavage fluid sample of the patient. In early January 2020, the viral genome sequence was released, which facilitated the development of rapid molecular diagnostics assays worldwide. Subsequently, the virus (now known as SARS-CoV-2, which causes the ongoing coronavirus disease 2019 (COVID-19) pandemic) rapidly spread globally, and there has been an immediate effort to study viral transmission and evolution using WGS. For example, SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/covid-data/spheres.html">SPHERES</ext-link>) in the United States and the COVID-19 Genomics UK<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://www.cogconsortium.uk">COG-UK</ext-link>) in the United Kingdom.<fig position="anchor" id="Figa"><caption><p>Philip Patenall/Springer Nature Limited</p></caption><graphic position="anchor" xlink:href="41579_2020_421_Figa_HTML" id="d30e160"/></fig></p><p id="Par4">The latter consortium was launched in March 2020 as a nationwide genomic surveillance network that aims&#x000a0;to track viral transmission, identify viral mutations and integrate viral data with health data<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. By June 2020, the consortium sequenced &#x0003e;20,000 SARS-CoV-2 genomes and defined transmission lineages based on phylogeny. Open data sharing and standardized lineage definitions (<ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/">Global Initiative on Sharing All Influenza Data</ext-link> (GISAID)) were established to enable global efforts in detecting emerging lineages and mutations that are relevant for outbreak control and vaccine development on an international level<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. By the end of June 2020, &#x0003e;57,000 SARS-CoV-2 genomes from around 100 different countries have been deposited in the GISAID database. To overcome the challenge in data analysis and interpretation, user-friendly web-based applications were designed for linage assignment (<ext-link ext-link-type="uri" xlink:href="https://pangolin.cog-uk.io/">Pangolin COVID-19 Lineage Assigner</ext-link>) and to interactively visualize the circulating lineages on national and international scales (for example, <ext-link ext-link-type="uri" xlink:href="https://microreact.org/showcase">Microreact</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://nextstrain.org/">Nextstrain</ext-link>).</p><p id="Par5">The international effort towards open data sharing is of major scientific benefit, enabling monitoring of SARS-CoV-2 evolution in&#x000a0;nearly real time and on a global level. Korber et al.<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> developed a bioinformatics pipeline to track changes in the SARS-CoV-2 spike glycoprotein, which mediates host cell entry and is a key vaccine target. The pipeline monitors changes in the amino acid sequence of spike over time to identify variants that are concomitantly increasing in frequency in different geographic locations. The analysis, which was enabled by data from GISAID, suggested that a SARS-CoV-2 variant carrying a particular spike mutation (D614G) became globally dominant over a period of one month. Comparison of different regions revealed consistent patterns of the D614 variant replacing a previously established G614 variant, which might be indicative of potential positive selection. The viral genome data were linked with patient clinical information, which showed that the G614 variant might be associated with potentially higher viral loads but not with disease severity. Updated data and current global counts of the spike 614 variants are available in the <ext-link ext-link-type="uri" xlink:href="https://cov.lanl.gov/content/index">COVID-19 Viral Genome Analysis Pipeline</ext-link>.</p><p id="Par6">Genomic surveillance can generate a rich source of information for tracking pathogen transmission and evolution on both national and international levels. More importantly, the recent application of genomics in surveillance of COVID-19 highlighted its usefulness&#x000a0;in the nearly real-time response to a public health crisis.</p></body><back><fn-group><fn><p><bold>Related links</bold></p><p><bold>COG-UK:</bold>
<ext-link ext-link-type="uri" xlink:href="https://www.cogconsortium.uk">https://www.cogconsortium.uk</ext-link>
</p><p><bold>COVID-19 Viral Genome Analysis pipeline:</bold>
<ext-link ext-link-type="uri" xlink:href="https://cov.lanl.gov/content/index">https://cov.lanl.gov/content/index</ext-link>
</p><p><bold>GISAID:</bold>
<ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/">https://www.gisaid.org/</ext-link>
</p><p><bold>Microreact:</bold>
<ext-link ext-link-type="uri" xlink:href="https://microreact.org/showcase">https://microreact.org/showcase</ext-link>
</p><p><bold>Nextstrain:</bold>
<ext-link ext-link-type="uri" xlink:href="https://nextstrain.org">https://nextstrain.org</ext-link>
</p><p><bold>Phylogenetic Assignment of Named Global Outbreak LINeages COVID-19 Lineage Assigner:</bold>
<ext-link ext-link-type="uri" xlink:href="https://pangolin.cog-uk.io/">https://pangolin.cog-uk.io/</ext-link>
</p><p><bold>SPHERES:</bold>
<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/covid-data/spheres.html">https://www.cdc.gov/coronavirus/2019-ncov/covid-data/spheres.html</ext-link>
</p></fn></fn-group><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par7">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><etal/></person-group><article-title>A new coronavirus associated with human respiratory disease in China</article-title><source>Nature</source><year>2020</year><volume>579</volume><fpage>265</fpage><lpage>269</lpage><?supplied-pmid 32015508?><pub-id pub-id-type="pmid">32015508</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The COVID-19 Genomics UK (COG-UK) consortium</collab></person-group><article-title>An integrated national scale SARS-CoV-2 genomic surveillance network</article-title><source>Lancet Microbe</source><year>2020</year><volume>1</volume><fpage>e99</fpage><lpage>e100</lpage></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. <italic>Nat. Microbiol</italic>. 10.1038/s41564-020-0770-5 (2020).</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korber</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus</article-title><source>Cell</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.043</pub-id></element-citation></ref></ref-list></back></article>